The study team evaluated two independent heart failure cohorts to test how different formulations of cardiovascular-kidney-metabolic (CKM) burden relate to prognosis. One cohort included patients with HF with reduced ejection fraction starting angiotensin receptor–neprilysin inhibitor therapy (HFrEF-ARNI; n=1,450). The second was a larger acute HF (AHF) cohort (n=2,985), which the authors stratified by left ventricular ejection fraction into LVEF <50% (HFrEF) and LVEF ≥50% (HFpEF). The investigators defined two CKM scores: a binary count of six CKM components and an HF-adapted graded score that incorporated chronic kidney disease severity and reverse-scored body mass index categories. The composite outcome analyzed was all-cause death or heart-failure hospitalization. Median follow-up differed between cohorts — 31.5 months for the HFrEF-ARNI group and 51.1 months for the AHF cohort.
In the HFrEF-ARNI cohort both CKM burden scores independently associated with the composite endpoint. The study team reported adjusted hazard ratios per 1-point increase of 1.10 (95% CI 1.02–1.18) for the binary score and 1.11 (95% CI 1.04–1.19) for the graded score. Those point estimates translate into modest incremental risk per unit increase. The authors used Cox regression for association testing; they also compared prognostic discrimination using C-index values. The source did not provide detailed event counts by CKM strata in the abstract, nor the full list of covariates included in each adjusted model beyond the statement that models were adjusted.
In the AHF cohort the CKM scores behaved differently by phenotype. Both scores associated with the composite outcome in patients with HFrEF. The HFpEF subgroup, however, showed a divergence: the binary score did not show a significant association (reported HR 0.96; 95% CI 0.90–1.02), whereas the graded score did (HR 1.09; 95% CI 1.04–1.15). The study team therefore observed statistically significant interactions between CKM burden and HF phenotype for both score formats. Those interaction tests indicate that the relationship between CKM burden and outcomes is not uniform across the HF spectrum.
The graded CKM score yielded higher discrimination than the binary score in both cohorts. Reported C-index values were 0.632 for the graded score versus 0.583 for the binary score in the HFrEF-ARNI cohort. In the AHF cohort the graded score C-index was 0.609 compared with 0.541 for the binary score. The relative improvement was most pronounced in HFpEF, where the graded score achieved a C-index of 0.576 compared with 0.491 for the binary measure. These findings suggest that incorporating disease severity elements—particularly chronic kidney disease staging and BMI categories adjusted for HF relevance—improves discrimination beyond a simple component count.
The authors assessed whether the graded CKM score added prognostic information beyond standard clinical and echocardiographic variables. In the HFpEF subgroup, only the graded score provided significant incremental prognostic information, with an incremental χ2 = 11.3 (P <0.001) reported in the abstract. That result indicates the graded formulation carried independent, additive value when layered on top of other risk markers in patients with preserved ejection fraction. The abstract did not list which specific clinical or echocardiographic variables were included in the incremental models; the source document would need to be consulted for covariate details and model specifications.
This report is posted as a preprint and has not undergone peer review. The authors declared institutional ethical approval and stated that underlying data are available from the corresponding author upon reasonable request. The abstract provides point estimates, confidence intervals, median follow-up durations, cohort sizes, and discrimination metrics; however, several granular details are not provided in the abstract itself. The source did not report, in the abstract, the six component items comprising the binary CKM count by name, the full variable list used for model adjustment, subgroup event counts, or calibration metrics for the scores. Those omissions limit immediate ability to evaluate potential applicability and transportability. The investigators also disclosed a consulting relationship for one author; all other authors reported no relevant relationships.
The study team observed that an HF-adapted graded CKM burden score showed more consistent prognostic associations and better risk discrimination than a simple binary score, with the largest gains seen in HFpEF. Whether the graded CKM score improves decision-making or clinical management in routine practice requires additional validation and peer-reviewed reporting of the full methods and results. Data access requests can be directed to the corresponding author as described in the preprint record.